Recalls and suspensions

Subscribe to TGA safety information
22 December 2021
Recall - Possible presence of benzene
16 December 2021
Device repair/replacement program - progress update
14 September 2021
Recall due to risk of bacterial contamination
2 August 2021
Recall - Possible presence of benzene

More safety information »

Safety information

Subscribe to TGA safety information
20 January 2022
Medicines Safety Update - Information for consumers
20 January 2022
Medicines Safety Update - Information for health professionals
20 January 2022
Acellur Dermal Matrix Products used in Breast Reconstruction - clarification on reports of potential higher complication rates.
20 January 2022
TGA's safety monitoring of COVID-19 vaccines.

More safety information »

News

Subscribe to TGA latest news and updates
21 January 2022
This webinar will guide advertisers through the new Therapeutic Goods Advertising Code 2021.
21 January 2022
TGA decision: Paxlovid (nirmatrelvir/ritonavir) is approved for the treatment of adults with COVID-19.
21 January 2022
TGA decision: Lagevrio (molnupiravir) is approved for the treatment of adults with COVID-19.
20 January 2022
Australian Public Assessment Report for SARS-CoV-2 rS with Matrix-M adjuvant

More news »